Welcome to Karyopharm

Karyopharm Therapeutics is a biopharmaceutical company focusing on the discovery and the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation.

Karyopharm Therapeutics is developing small molecule drugs that modulate the activity of critical pathways in cancer, inflammation, and cell proliferation by targeting the nuclear pore complex machinery, which controls the import and export of key regulatory and tumor suppressor proteins between the nucleus and cytoplasm.
Read more >

Visit our Careers Page

We are now hiring. Click here >

Our Mission . . .

is to discover and develop new therapies to treat and cure diseases such as cancer, and inflammation, and viral infection.
Click here >